Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ten-year seroprotection after fractional-dose yellow fever vaccination
NL-OMON29660Suspended
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2017
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of 17D yellow fever vaccine in yellow fever (2 cohorts), sponsored by Leiden University Medical Center. Primary endpoint: Neutralizing antibody response ten years after yellow fever vaccination. Started Jan 2017; status: suspended.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NL-OMON29660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29660.